Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01613508 · ClinicalTrials.gov registry record · NA

A Randomized Study of Approaches in Total Hip Arthroplasty

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
116
Enrollment target

NCT01613508: Completed NA study, sponsored by Mayo Clinic.

NCT01613508 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 116 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01613508, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
116 participants
Enrollment target

Study Summary

The primary aim of the study is to compare the results of an established, successful procedure, which is total hip arthroplasty through a mini-posterior approach to a less studied - increasingly popular procedure, which is total hip replacement through the direct anterior approach utilizing the orthopedic table.

Primary Outcome

3 monitoring sensors will be worn by the subject.

Interventions

  • PROCEDURE Direct Anterior Approach
  • PROCEDURE Mini-Posterior Approach

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2013-01
Est. Completion 2018-02-27
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT01613508 record still lists

NCT01613508 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Direct Anterior Approach is the first listed.

NCT01613508 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01613508 about?

NCT01613508 is a clinical study titled "A Randomized Study of Approaches in Total Hip Arthroplasty". The primary aim of the study is to compare the results of an established, successful procedure, which is total hip arthroplasty through a mini-posterior approach to a less studied - increasingly popular procedure, which is total hip replacement through the direct anterior approach utilizing the orth...

What is the current status of trial NCT01613508?

This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2013-01. Estimated completion is 2018-02-27.

What interventions are being tested in trial NCT01613508?

The interventions under investigation include: Direct Anterior Approach (PROCEDURE), Mini-Posterior Approach (PROCEDURE).

Who is sponsoring clinical trial NCT01613508?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01613508's enrollment target sits among peer trials

116 808th of 2000 higher than 1,191 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03014687 · 116 participants · Phase 4

    Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions

  • NCT03214562 · 116 participants · Phase 1

    Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

  • NCT03847467 · 116 participants · Phase 1

    Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

  • NCT04222413 · 116 participants · Phase 1

    Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01613508, the US trial registry maintained by the National Library of Medicine. NCT01613508 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.